EN
HI
Supriya Lifescience share price chart
Supriya Lifescience Share Key Metrics
Volume
2.25 L
Market Cap
6309.85 CR
LTQ@LTP
1@814.00
ATP
808.48
Var Margin
24.22 %
Circuit Range
627.2-940.8
Delivery %
52.27 %
Value
18.21 CR
ASM/GSM
No
Market Lot
1
Summary
SUPRIYA stock price is ₹814 as of 18 Aug, 2026. The stock intraday movement has stayed between ₹781.60 and ₹824.00, while Supriya Lifescience share price 52 week high low is ₹545.50 & ₹1085.00.
In terms of trading activity, SUPRIYA share price has recorded a volume of 2,25,265 shares. The Supriya Lifescience has a market cap of ₹80482800. The stock’s Average Traded Price (ATP) stands at ₹808.48, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹814.00.
The Supriya Lifescience upper circuit limit is ₹940.80 & The Supriya Lifescience lower circuit limit is ₹627.20, with a Value of ₹18.21 CR. The Delivery Percentage for the day is 52.27%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Supriya Lifescience Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
63.29
Sector P/B
3.31
Sec. Div. Yield
0.51
Supriya Lifescience Resistance and Support
Pivot 790.23
Resistance
First Resistance
800.61
Second Resistance
817.23
Third Resistance
827.61
Support
First Support
773.61
Second Support
763.23
Third Support
746.61
Supriya Lifescience Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Aug 18 2026 | 784 | 814 | 3.83% | 824 | 781.6 |
| Mon Aug 17 2026 | 791.65 | 784 | -0.97% | 806.84 | 779.84 |
| Fri Aug 14 2026 | 745 | 791.65 | -2.69% | 813 | 740.45 |
Supriya Lifescience Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-13 | Quarterly Results |
| 2026-05-27 | Audited Results & Final Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-27 | Audited Results & Final Dividend |
| 2025-03-10 | Others |
| 2025-01-24 | Quarterly Results & Others |
| 2024-10-28 | Quarterly Results |
| 2024-08-10 | Quarterly Results |
Supriya Lifescience News
Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Supriya Lifescience reported Q1 FY27 unaudited financial results. Revenue increased 30.8% YoY to Rs.189.75 crore, driven by strong export contribution (81%). However, net profit declined 30.9% to Rs.24.04 crore, and EBITDA fell 8.2% to Rs.47.46 crore, impacting margins.
Aug 13 2026 23:26:41
Supriya Lifescience Ltd - 543434 - Board Meeting Intimation for Unaudited Financial Results For Quarter Ended June 2026
Supriya Lifescience announced that its Board of Directors will meet on August 13, 2026. The meeting will primarily focus on considering and approving the unaudited financial results for the quarter ended June 30, 2026.
Aug 06 2026 18:23:16
Read More
Supriya Lifescience Management
| Name | Position |
|---|---|
| Prachi Sathe | Company Secretary & Compliance Officer |
| Satish Waman Wagh | Chairman |
Supriya Lifescience Similar Stocks
Kovai Medical Center & Hospital Ltd.
6076.50
-45.50 (0.74%)
Orchid Pharma Ltd.
974.30
-24.05 (2.41%)
Innova Captab Ltd.
1055.65
17.20 (1.66%)
FDC Ltd.
353.90
-0.40 (0.11%)
Bliss GVS Pharma Ltd.
528.95
8.45 (1.62%)
Artemis Medicare Services Ltd.
311.60
-2.80 (0.89%)
IOL Chemicals And Pharmaceuticals Ltd.
159.81
-1.47 (0.91%)
Morepen Laboratories Ltd.
90.12
0.30 (0.33%)
RPG Life Sciences Ltd.
2740.00
-1.30 (0.05%)
Gufic Biosciences Ltd.
414.80
-3.40 (0.81%)
Supriya Lifescience FAQs
The Buying Price of Supriya Lifescience share is 814 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Supriya Lifescience stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Supriya Lifescience, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Supriya Lifescience shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Supriya Lifescience shares is 0. Useful to assess the stock's value relative to its book value.
To assess Supriya Lifescience’s valuation compare Sector P/E, P/B which are 63.29 & 3.31 with sector averages, along with growth rates and financial metrics.
The Market Cap of Supriya Lifescience is 6309.85 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Supriya Lifescience share price is 1085.00 & 545.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Supriya Lifescience belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
